Literature DB >> 31786271

Modulation of hippocampal TLR4/BDNF signal pathway using probiotics is a step closer towards treating cognitive impairment in NASH model.

Safaa K Mohammed1, Yosra M Magdy2, Dalia Aa El-Waseef3, Enas S Nabih4, Mohamed A Hamouda5, Omnyah A El-Kharashi6.   

Abstract

BACKGROUND AND AIM: Disturbance of gut microbiota plays a role in induction and progression of non alcoholic steatohepatitis (NASH) and the associated cognitive dysfunction. We supposed that high fat diet (HFD)-induced dysbiosis may lead to NASH/cognitive impairment co-morbidities through hippocampal TLR4/BDNF signaling pathway and the regaining of microbiota balance through probiotics could provide a therapeutic option.
METHODOLOGY: Four groups of male Wister rats were used; Naïve, Lactobacillus Plantarum EMCC-1039 (LP EMCC-1039), NASH and NASH+ LP EMCC-1039 groups. After induction of NASH with high fat diet (HFD), LP EMCC-1039 was given daily by oral gavage in the last two weeks of experiment to the treated group. Body weight percentage (BW%) changes, Lee index (LI), liver function tests, expression of BDNF, TLR4 with RT-PCR and quantification of BDNF, TLR4 by ELISA were measured . Histological studies and assessment of cognitive function were also performed.
RESULTS: NASH group showed an increase in BW% and LI . It was associated with cognitive deficits, an increase in hepatic, hippocampal TLR4 expression and decline in BDNF expression and protein, all p values were <0.05. Histological examination revealed significant decrease in number of viable cells and shrinking of pyramidal cells in hippocampus (p<0.05). Treatment with LP EMCC-1039 improved all these pathological changes significantly (p<0.05) with negative correlation between NAFLD activity score (NAS) and cognitive measurements. Additionally, hepatic and hippocampal TLR4 expression were decreased and BDNF expression and quantity were increased.
CONCLUSIONS: Dysbiosis-induced NASH was associated with cognitive impairment and a probiotic (LP EMCC-1039) supplementation has beneficial effect through modulation of TLR4/BDNF signaling pathway.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BDNF; Cognition; Dysbiosis; NASH; TLR4

Year:  2019        PMID: 31786271     DOI: 10.1016/j.physbeh.2019.112762

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  9 in total

1.  Non-alcoholic Fatty Liver Disease: Also a Disease of the Brain? A Systematic Review of the Preclinical Evidence.

Authors:  Anne Catrine Daugaard Mikkelsen; Kristoffer Kjærgaard; Rajeshwar Prosad Mookerjee; Hendrik Vilstrup; Gregers Wegener; Cecilie Bay-Richter; Karen Louise Thomsen
Journal:  Neurochem Res       Date:  2022-03-01       Impact factor: 3.996

Review 2.  Roles of Gut Microbiota in the Regulation of Hippocampal Plasticity, Inflammation, and Hippocampus-Dependent Behaviors.

Authors:  Wen Tang; Zhaoyou Meng; Ning Li; Yiyan Liu; Li Li; Dongfeng Chen; Yang Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-01-27       Impact factor: 5.293

Review 3.  Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives.

Authors:  Kristoffer Kjærgaard; Anne Catrine Daugaard Mikkelsen; Charlotte Wilhelmina Wernberg; Lea Ladegaard Grønkjær; Peter Lykke Eriksen; Malene Flensborg Damholdt; Rajeshwar Prosad Mookerjee; Hendrik Vilstrup; Mette Munk Lauridsen; Karen Louise Thomsen
Journal:  J Clin Med       Date:  2021-02-09       Impact factor: 4.241

Review 4.  The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis.

Authors:  Hui Xiang; Dating Sun; Xin Liu; Zhi-Gang She; Yonghong Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-08       Impact factor: 5.555

5.  Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4/NF-kB signaling pathway.

Authors:  Zhiwei Wu; Entezar Mehrabi Nasab; Poonam Arora; Seyyed Shamsadin Athari
Journal:  J Transl Med       Date:  2022-03-16       Impact factor: 5.531

6.  Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review.

Authors:  Faezah Sabirin; Siong Meng Lim; Chin Fen Neoh; Kalavathy Ramasamy
Journal:  Front Nutr       Date:  2022-04-11

Review 7.  Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation.

Authors:  So Yeong Cheon; Juhyun Song
Journal:  Cell Biosci       Date:  2022-06-28       Impact factor: 9.584

Review 8.  Research Advances in the Treatment of Allergic Rhinitis by Probiotics.

Authors:  Peng Liu; Tianyong Hu; Chenglin Kang; Jiangqi Liu; Jin Zhang; Hong Ran; Xianhai Zeng; Shuqi Qiu
Journal:  J Asthma Allergy       Date:  2022-10-07

Review 9.  The effect of probiotics on lipid profile & anthropometric indices in diabetic nephropathy; a systematic review and meta-analysis of clinical trials.

Authors:  Amir Reza Moravejolahkami; Mohammad Ali Hojjati Kermani; Zakiyeh Balouch Zehi; Seyed Mohammad Sadegh Mirenayat; Marjan Mansourian
Journal:  J Diabetes Metab Disord       Date:  2021-02-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.